Cargando…

ACE Inhibitor Benefit to Kidney and Cardiovascular Outcomes for Patients with Non-Dialysis Chronic Kidney Disease Stages 3–5: A Network Meta-Analysis of Randomised Clinical Trials

BACKGROUND: The advantages of angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin II receptor blockers (ARBs) in reducing risk of cardiovascular events (CVEs) and delaying end-stage kidney disease (ESKD) in patients with chronic kidney disease (CKD) is well-known. However, the efficacy a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Yaru, He, Dandan, Zhang, Wei, Xing, Yue, Guo, Yipeng, Wang, Fuzhen, Jia, Junya, Yan, Tiekun, Liu, Youxia, Lin, Shan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242277/ https://www.ncbi.nlm.nih.gov/pubmed/32333236 http://dx.doi.org/10.1007/s40265-020-01290-3

Ejemplares similares

Effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on cardiovascular events and residual renal function in dialysis patients: a meta-analysis of randomised controlled trials
por: Liu, Youxia, et al.
Publicado: (2017)

C1GALT1 expression is associated with galactosylation of IgA1 in peripheral B lymphocyte in immunoglobulin a nephropathy
por: Xing, Yue, et al.
Publicado: (2020)

ST6Gal1 is up‐regulated and associated with aberrant IgA1 glycosylation in IgA nephropathy: An integrated analysis of the transcriptome
por: Liu, Youxia, et al.
Publicado: (2020)

Pregnancy outcomes in patients with acute kidney injury during pregnancy: a systematic review and meta-analysis
por: Liu, Youxia, et al.
Publicado: (2017)

The difference between patients with nephrotic syndrome and nephrotic-range proteinuria in IgA nephropathy: a propensity score matched cohort study
por: Li, Hongfen, et al.
Publicado: (2022)

Effect and safety of LCZ696 in the treatment of hypertension: A meta-analysis of 9 RCT studies
por: Li, Qiongqiong, et al.
Publicado: (2019)

ELL2 Is Downregulated and Associated with Galactose-Deficient IgA1 in IgA Nephropathy
por: Liu, Youxia, et al.
Publicado: (2019)

Comprehensive analysis of aberrantly expressed profiles of mRNA and its relationship with serum galactose-deficient IgA1 level in IgA nephropathy
por: Liu, Youxia, et al.
Publicado: (2019)

Elevated activating Fc gamma receptors levels correlated with susceptibility and severity of IgA nephropathy
por: Li, Hongfen, et al.
Publicado: (2022)

Reduced cortical complexity in patients with end-stage kidney disease prior to dialysis initiation
por: Yuan, Huijie, et al.
Publicado: (2022)

Sialylation of IgG inhibits the formation of galactose-deficient IgA1-containing immune complexes and protects mesangial cells from injury in IgA nephropathy
por: Liu, Youxia, et al.
Publicado: (2022)

Exploring the pathogenesis of diabetic kidney disease by microarray data analysis
por: Cao, Haiyan, et al.
Publicado: (2022)

Diffusion-weighted imaging for staging chronic kidney disease: a meta-analysis
por: Liu, Haitian, et al.
Publicado: (2018)

Sustained Recovery of Kidney Function in Patients with ESKD under Chronic Dialysis Treatment: Systematic Review and Meta-Analysis
por: Garofalo, Carlo, et al.
Publicado: (2023)

Changes E3 ubiquitin protein ligase 1 gene mRNA expression correlated with IgA1 glycosylation in patients with IgA nephropathy
por: Liu, Youxia, et al.
Publicado: (2019)

Contrast-Induced Encephalopathy in Patients with Chronic Kidney Disease and End-Stage Kidney Disease: A Systematic Review and Meta-Analysis
por: Davis, Paul W., et al.
Publicado: (2023)

Role of ACE, ACE2 and Neprilysin in the Kidney
por: Chappell, Mark C.
Publicado: (2007)

Prevalence and Severity of Lower Gastrointestinal Symptoms amongst Non-Dialysis Chronic Kidney Disease Patients: A Systematic Review and Meta-Analysis
por: Ruszkowski, Jakub, et al.
Publicado: (2022)

Plasma ST6GAL1 regulates IgG sialylation to control IgA nephropathy progression
por: Liu, Youxia, et al.
Publicado: (2021)

Therapy in the Course of Kidney Graft Rejection—Implications for the Cardiovascular System—A Systematic Review
por: Mizera, Jakub, et al.
Publicado: (2023)

Autonomic Cardiovascular Alterations in Chronic Kidney Disease: Effects of Dialysis, Kidney Transplantation, and Renal Denervation
por: Quarti-Trevano, Fosca, et al.
Publicado: (2021)

Cardiovascular complications after COVID-19 in chronic kidney disease, dialysis and kidney transplant patients
por: Loutradis, Charalampos, et al.
Publicado: (2021)

Atrial Fibrillation in Patients with End-stage Kidney Disease on Dialysis
por: Watanabe, Hiroshi, et al.
Publicado: (2018)

Metabolomics Evaluation of Patients With Stage 5 Chronic Kidney Disease Before Dialysis, Maintenance Hemodialysis, and Peritoneal Dialysis
por: Zhu, Sang, et al.
Publicado: (2021)

Kidney ACE2 expression: Implications for chronic kidney disease
por: Maksimowski, Nicholas, et al.
Publicado: (2020)

Computational Models Used to Predict Cardiovascular Complications in Chronic Kidney Disease Patients: A Systematic Review
por: Burlacu, Alexandru, et al.
Publicado: (2021)

Peritoneal dialysis catheter removal at the time or after kidney transplantation: a systematic review and meta-analysis
por: Zawistowski, Michał, et al.
Publicado: (2022)

Epidemiology and aetiology of dialysis-treated end-stage kidney disease in Libya
por: Alashek, Wiam A, et al.
Publicado: (2012)

Dialysis and Pregnancy in End Stage Kidney Disease Associated with Lupus Nephritis
por: Sivasuthan, Goutham, et al.
Publicado: (2013)

Magnesium in chronic kidney disease Stages 3 and 4 and in dialysis patients
por: Cunningham, John, et al.
Publicado: (2012)

Nutritional evaluation of stage 5 chronic kidney disease patients on dialysis
por: Piratelli, Cynthia Mauro, et al.
Publicado: (2013)

Acute kidney injury in the context of staged revision arthroplasty and the use of antibiotic-laden cement spacers: a systematic review
por: Chaudhry, Yash P., et al.
Publicado: (2023)

Clinical and Epidemiological Profiles of Patients with End Stage Kidney Disease on Dialysis at Dialysis Centers in Addis Ababa, Ethiopia
por: Seifu, Lissane, et al.
Publicado: (2023)

Reducing the risk of infection in end-stage kidney failure patients treated by dialysis
por: Collier, Sophie, et al.
Publicado: (2014)

Hip fracture in patients with non-dialysis chronic kidney disease stage 5
por: Tang, Chao-Hsiun, et al.
Publicado: (2021)

Hydralazine–Isosorbide Dinitrate Use in Patients With End-Stage Kidney Disease on Dialysis
por: Mavrakanas, Thomas A., et al.
Publicado: (2022)

Supporting Shared Decision-Making and Home Dialysis in End-Stage Kidney Disease
por: Campbell-Montalvo, Rebecca, et al.
Publicado: (2022)

Comorbidity is not associated with dialysis modality choice in patients with end‐stage kidney disease
por: Bonenkamp, Anna A., et al.
Publicado: (2022)

Nutritional management of the infant with chronic kidney disease stages 2–5 and on dialysis
por: Shaw, Vanessa, et al.
Publicado: (2022)

One Heartbeat Away from a Prediction Model for Cardiovascular Diseases in Patients with Chronic Kidney Disease: A Systematic Review
por: Smit, Leanne C.M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_l0dbo0rh5pv504o1r6729glrvg